Michael Rettig, PhD

Michael Rettig, PhD

Primary Academic Title

Professor of Medicine, Division of Oncology, Section of Stem Cell Biology, Washington University School of Medicine

Research Interest

Developing strategies that will maximize the graft-versus-leukemia (GVL) effect while minimizing graft- versus-host disease (GVHD) after allogeneic hematopoietic stem-cell transplantation.

Education

  • 2000: PhD, chemistry, Purdue University, West Lafayette, Ind.

Training

  • 2000 - 2003: Postdoctoral fellow, oncology, Washington University, St. Louis

Selected Research Publications

Phase 1/2 trial of anti-CD7 allogeneic WU-CART-007 for patients with relapsed/refractory T-cell malignancies.
  • Ghobadi A, Aldoss I, Maude SL, [...] Rettig MP, [...] DiPersio JF
  • Blood 2025
An "off-the-shelf" CD2 universal CAR-T therapy for T-cell malignancies.
  • Xiang J, Devenport JM, Carter AJ, [...] Rettig MP, [...] DiPersio JF
  • Leukemia 2023

View All Publications